Support for this notion came from the observation that the MEK inhibitor U0126 attenuates hepatocyte growth factor-induced proliferation in human granulosa-like tumor cell line (KGN cells) [32] and insulin-like growth factor 1-induced, AKT-mediated proliferation in human luteinized granulosa cells [33]. This evidence concerns the gene AKT1 and neoplasm.